Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity
Multiple myeloma still appears to be an incurable hematological malignancy. One of the reasons is that myeloma cells can be ...
Tag: myeloma
Sylvester research shows how interactions between tumor genes and microenvironment influence treatment response in multiple myeloma
MIAMI, FLORIDA (EMBARGOED UNTIL NOV. 9, 2023, AT 11 A.M. ET) – A multicenter study led by researchers at Sylvester ...
Intravenous immunoglobulin may prevent severe infections associated with anti-BCMA therapy for multiple myeloma
Bottom Line: Intravenous immunoglobulin (IVIg) reduced the risk of severe infections by 90% in patients with multiple myeloma undergoing treatment ...
A dendritic cell vaccine was safe and induced immune responses in patients with multiple myeloma
Bottom Line: A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and ...
Immune system plays vital role in longer multiple myeloma remission
MIAMI, FLORIDA (Sept. 6, 2023) – A new study from researchers with Sylvester Comprehensive Cancer Center at the University of ...
Sylvester researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy
MIAMI, FLORIDA (EMBARGOED UNTIL AUG. 31, 2023 AT 11 A.M. ET) – Researchers at Sylvester Comprehensive Cancer Center at the ...
Embargoed – Potent oral agent that acts as both immunotherapy and targeted treatment produces high response rate in patients with hard-to-treat and refractory multiple myeloma when combined with steroid, trial shows
EMBARGOED: August 30, 2023, 5PM EST Contact: Nicole Oliverio, 617-257-0454, nicole_oliverio@dfci.harvard.edu Potent Oral Agent That Acts as Both Immunotherapy and ...
Study brings new understanding of multiple myeloma evolution
HOUSTON – A new study by researchers at The University of Texas MD Anderson Cancer Center highlights novel insights into ...
Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from racial and ethnic minorities
(WASHINGTON, May 4, 2023) – Numerous studies have shown that people from racial and ethnic minority groups are underrepresented in ...
Investigational drug may improve stem cell transplantation for multiple myeloma patients
The standard treatment for patients with multiple myeloma often includes stem cell transplantation in which the patient’s own stem cells ...
Scientists create mouse avatars to treat multiple myeloma
Credit: Manuel Castells. Scientists create mouse avatars to treat multiple myeloma Cima University of Navarra (Spain) researchers lead an ...
Novel disease models for multiple myeloma
B lymphocytes – also known simply as B cells – play a central role in the immune system. If pathogens enter the ...
Molecular basis of resistance to one of the main treatments for multiple myeloma identified
Multiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibodies. ...
Oncotarget | The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
“We demonstrate that matriptase overexpression in vitro was associated with reduced myeloma cell proliferation and that matriptase significantly inhibited myeloma ...
Taking aim at triple-negative breast cancer and multiple myeloma to improve prognoses
HOUSTON-(Sept. 27, 2022) – Two Houston Methodist cancer researchers have been awarded a half million dollars in funding from the ...
Novel photon-counting CT improves myeloma bone disease detection
OAK BROOK, Ill. – New CT technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease ...
Stanford cancer team halts growth of multiple myeloma and diffuse large B cell lymphoma in mice with custom molecule sBCMA-Fc V3
Researchers at Stanford University have developed “decoy receptor” molecules that inhibit the growth of both multiple myeloma (MM) and diffuse ...
Exploring the R-ISS stage-specific regular networks in the progression of Multiple Myeloma at single-cell resolution
Multiple myeloma (MM) is the second most common blood cancer, characterised by the accumulation and proliferation of terminally differentiated plasma ...
Caregivers for people with multiple myeloma face mental health challenges
(WASHINGTON, July 18, 2022) – Caregivers for patients with multiple myeloma may suffer from higher rates of anxiety and depression ...
Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant
BOSTON – Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of ...
-
Scientists discover rare 6-planet system that moves in strange synchrony
-
Ohio State receives $14 million to study optimal aspirin therapy in pregnancy
-
AI image generator Stable Diffusion perpetuates racial and gendered stereotypes, study finds
-
‘Dolomite Problem’: 200-year-old geology mystery resolved
-
The dangers of being a saber-toothed cat in Los Angeles 12,000 years ago
-
Rise of microplastics discovered in placentas of Hawaiʻi mothers